NASDAQ
Ultralife Corporation (ULBI)
♥ 588 Thanks from members
Ultralife Corporation (ULBI) exhibits a positive market reaction following Q2 2026 earnings, highlighted by a record backlog and surging EPS, despite minor revenue dips and mixed commercial segment performance.